by Aline Fieck | Dec 1, 2025 | Featured
Qynapse participated alongside Paris Santé Campus at the Adopt AI congress in Paris, highlighting its commitment to advancing AI-driven innovations in neuroscience and digital...
by Aline Fieck | Dec 1, 2025 | Featured, News, Updates
PARIS, FRANCE, December 1, 2025 – Qynapse is present at CTAD Clinical Trials on Alzheimer’s Disease 2025 in San Diego. Meet Olivier Courrèges and Michael Tunkelrott and discover how Qynapse’s clinically validated AI solutions are advancing Alzheimer’s disease...
by Aline Fieck | Jul 27, 2025 | Featured, News
Toronto, Canada – July 28, 2025 – Qynapse, a technology company using AI to enhance the quantification and predictive capabilities of imaging to improve outcomes for neurological diseases, including Alzheimer’s disease (AD), presented new data at the Alzheimer’s...
by Aline Fieck | May 6, 2025 | Featured, News, Updates
PARIS, FRANCE, May 6, 2025 – We are thrilled to share that Qynapse’s collaborative study with Amsterdam UMC has been published in Alzheimer’s Research & Therapy: “Clinical phenotypes of Alzheimer’s disease: investigating atrophy patterns and their pathological...
by Aline Fieck | Apr 5, 2025 | Featured, News
PARIS, FRANCE, April 5, 2025 –Dr. Luca Villa, Senior Clinical Scientist, presented our work focused on using QyScore® and QyPredict® to differentiate patients with progressive supranuclear palsy from patients with Parkinson’s disease. The presentation, titled...
by Aline Fieck | Feb 12, 2025 | Featured, News
PARIS, FRANCE, February 12, 2024 – Qynapse had the pleasure of participating in “Challenges of AI in Healthcare”, an event organized by PariSanté Campus and French Healthcare Association as part of the AI Action Summit in Paris. This gathering brought...